Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First-In-Human, Randomised, Double-Blind, Controlled Pilot Study to Evaluate the Safety and Tolerability of Microneedle Solutions Ltd's Unloaded and Fixed-Dose Tetanus- Containing Vaccine Loaded Miracus™ Patch in Healthy Adults

NCT07624669 is registered in ClinicalTrials.gov with Microneedle Solutions Ltd as lead sponsor.

NCT NCT07624669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07624669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First-In-Human, Randomised, Double-Blind, Controlled Pilot Study to Evaluate the Safety and Tolerability of Microneedle Solutions Ltd's Unloaded and Fixed-Dose Tetanus- Containing Vaccine Loaded Miracus™ Patch in Healthy Adults
Lead sponsor
Microneedle Solutions Ltd
Phase
Phase 4
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
November 30, 2026
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

tetanus, vaccine delivery